| Disease Term | Human Homologs | Mouse Homologs | Mouse Models | Homology Source | |||
  | aromatase excess syndrome | CYP19A1* | Cyp19a1* | 1 model | Alliance of Genome Resources | ||
| ovarian cancer | CTNNB1* | Ctnnb1* | 6 models | Alliance of Genome Resources | |||
| persistent Mullerian duct syndrome | AMHR2* | Amhr2* | 1 model | Alliance of Genome Resources | |||
| primary ovarian insufficiency 12 | SYCE1* | Syce1* | 1 model | Alliance of Genome Resources | |||
| primary ovarian insufficiency 13 | MSH5* | Msh5* | 1 model | Alliance of Genome Resources | |||
| primary ovarian insufficiency 19 | HSF2BP* | Hsf2bp* | 1 model | Alliance of Genome Resources | |||
| prostate cancer | ACP3* | Acp3* | 1 model | Alliance of Genome Resources | |||
| prostate cancer | APC* | Apc* | 1 model | Alliance of Genome Resources | |||
| prostate cancer | PTEN* | Pten* | 20 models | Alliance of Genome Resources | |||
| spermatogenic failure 19 | CFAP43* | Cfap43* | 2 models | Alliance of Genome Resources | |||
| spermatogenic failure 20 | CFAP44* | Cfap44* | 1 model | Alliance of Genome Resources | |||
| spermatogenic failure 24 | CFAP69* | Cfap69* | 2 models | Alliance of Genome Resources | |||
| spermatogenic failure 31 | PMFBP1* | Pmfbp1* | 1 model | Alliance of Genome Resources | |||
| spermatogenic failure 39 | DNAH17* | Dnah17* | 1 model | Alliance of Genome Resources | |||
| spermatogenic failure 40 | CFAP65* | Cfap65* | 1 model | Alliance of Genome Resources | |||
| spermatogenic failure 46 | DNAH8* | Dnah8* | 1 model | Alliance of Genome Resources | |||
| spermatogenic failure 47 | DZIP1* | Dzip1* | 1 model | Alliance of Genome Resources | |||
| | azoospermia | SYCP3 | Sycp3*, Gm773 | 1 model | Alliance of Genome Resources | ||
| azoospermia | GOPC | Gopc* | 1 model | Alliance of Genome Resources | |||
| dermoid cyst of ovary | FOXO3, FOXO3B | Foxo3* | 1 model | Alliance of Genome Resources | |||
| endometrial cancer | ERRFI1 | Errfi1* | 2 models | Alliance of Genome Resources | |||
| endometrial cancer | PTEN | Pten* | 3 models | Alliance of Genome Resources | |||
| endometrial cancer | STK11 | Stk11* | 1 model | Alliance of Genome Resources | |||
| endometrial cancer | TP53 | Trp53* | 2 models | Alliance of Genome Resources | |||
| endometriosis | KRAS | Kras* | 1 model | Alliance of Genome Resources | |||
| endometriosis | HDAC3 | Hdac3* | 1 model | Alliance of Genome Resources | |||
| female reproductive system disease | DEFB119 | Defb19* | 1 model | Alliance of Genome Resources | |||
| granulosa cell tumor | CTNNB1 | Ctnnb1* | 6 models | Alliance of Genome Resources | |||
| impotence | ADAMTSL2 | Adamtsl2* | 1 model | Alliance of Genome Resources | |||
| infertility | CDC23 | Cdc23* | 1 model | Alliance of Genome Resources | |||
| male infertility | PMFBP1 | Pmfbp1* | 1 model | Alliance of Genome Resources | |||
| male infertility | ARL2BP | Arl2bp* | 1 model | Alliance of Genome Resources | |||
| male infertility | ARMC2 | Armc2* | 1 model | Alliance of Genome Resources | |||
| male infertility | BSCL2 | Bscl2* | 1 model | Alliance of Genome Resources | |||
| male infertility | CABYR | Cabyr* | 1 model | Alliance of Genome Resources | |||
| male infertility | CCDC146 | Ccdc146* | 1 model | Alliance of Genome Resources | |||
| male infertility | CFAP47 | Cfap47* | 1 model | Alliance of Genome Resources | |||
| male infertility | CFAP57 | Cfap57* | 1 model | Alliance of Genome Resources | |||
| male infertility | CSNK2A2 | Csnk2a2* | 1 model | Alliance of Genome Resources | |||
| male infertility | CYLC1 | Cylc1* | 2 models | Alliance of Genome Resources | |||
| male infertility | DNAAF5 | Dnaaf5* | 1 model | Alliance of Genome Resources | |||
| male infertility | SPATA16 | Spata16* | 1 model | Alliance of Genome Resources | |||
| male infertility | TCTE1 | Tcte1* | 1 model | Alliance of Genome Resources | |||
| male infertility | Tsga8* | 2 models | |||||
| male infertility due to acephalic spermatozoa | CCDC159 | Ccdc159* | 1 model | Alliance of Genome Resources | |||
| male infertility due to globozoospermia | HSP90B1, HSP90B2P | Hsp90b1* | 1 model | Alliance of Genome Resources | |||
| oligoasthenoteratozoospermia | CFAP70 | Cfap70* | 2 models | Alliance of Genome Resources | |||
| oligoasthenoteratozoospermia | MLX | Mlx* | 1 model | Alliance of Genome Resources | |||
| oligoasthenoteratozoospermia | POC1B | Poc1b* | 1 model | Alliance of Genome Resources | |||
| oligoasthenoteratozoospermia | PPP4C | Ppp4c* | 1 model | Alliance of Genome Resources | |||
| oligoasthenoteratozoospermia | CFAP61 | Cfap61* | 1 model | Alliance of Genome Resources | |||
| oligoasthenoteratozoospermia | CCDC157 | Ccdc157* | 1 model | Alliance of Genome Resources | |||
| oligoasthenoteratozoospermia | AGFG1 | Agfg1* | 1 model | Alliance of Genome Resources | |||
| oligoasthenoteratozoospermia | SPATA20 | Spata20* | 1 model | Alliance of Genome Resources | |||
| oligoasthenoteratozoospermia | CFAP58 | Cfap58* | 1 model | Alliance of Genome Resources | |||
| ovarian cancer | APC | Apc* | 2 models | Alliance of Genome Resources | |||
| ovarian disease | PATL2 | Patl2* | 1 model | Alliance of Genome Resources | |||
| ovarian hyperstimulation syndrome | NR1H3 | Nr1h3* | 1 model | Alliance of Genome Resources | |||
| placental insufficiency | EMP2 | Emp2* | 1 model | Alliance of Genome Resources | |||
| polycystic ovary syndrome | AKT2 | Akt2* | 1 model | Alliance of Genome Resources | |||
| primary ovarian insufficiency | POLR3H | Polr3h* | 1 model | Alliance of Genome Resources | |||
| primary ovarian insufficiency | FANCF | Fancf* | 1 model | Alliance of Genome Resources | |||
| prostate cancer | CTNNB1 | Ctnnb1* | 2 models | Alliance of Genome Resources | |||
| prostate cancer | KRAS | Kras* | 4 models | Alliance of Genome Resources | |||
| prostate cancer | MSMB | Msmb* | 1 model | Alliance of Genome Resources | |||
| prostate cancer | NKX3-1 | Nkx3-1* | 7 models | Alliance of Genome Resources | |||
| prostate cancer | TGFBR2 | Tgfbr2* | 1 model | Alliance of Genome Resources | |||
| Sertoli cell-only syndrome | MAST4 | Mast4* | 1 model | Alliance of Genome Resources | |||
| Sertoli cell-only syndrome | DMC1 | Dmc1* | 1 model | Alliance of Genome Resources | |||
| Sertoli cell-only syndrome | NUPR1 | Nupr1* | 1 model | Alliance of Genome Resources | |||
| spermatogenic failure | CCDC34 | Ccdc34* | 1 model | Alliance of Genome Resources | |||
| spermatogenic failure | DNAH10 | Dnah10* | 2 models | Alliance of Genome Resources | |||
| uterine cancer | HMGA1 | Hmga1*, Hmga1b | 1 model | Alliance of Genome Resources | |||
| uterine fibroid | TSC2 | Tsc2* | 1 model | Alliance of Genome Resources | |||
| | amenorrhea | FSHB* | Fshb | Alliance of Genome Resources | |||
| autosomal recessive congenital bilateral absence of vas deferens | CFTR* | Cftr | Alliance of Genome Resources | ||||
| azoospermia | ERCC1* | Ercc1 | Alliance of Genome Resources | ||||
| azoospermia | BRDT* | Brdt | Alliance of Genome Resources | ||||
| bacterial vaginosis | MBL2* | Mbl2 | Alliance of Genome Resources | ||||
| castration-resistant prostate carcinoma | CCNE2* | Ccne2 | Alliance of Genome Resources | ||||
| castration-resistant prostate carcinoma | CHD1* | Chd1 | Alliance of Genome Resources | ||||
| castration-resistant prostate carcinoma | NUF2* | Nuf2 | Alliance of Genome Resources | ||||
| cervical cancer | TAP1* | Tap1 | Alliance of Genome Resources | ||||
| cervical cancer | TNFRSF10A*, TNFRSF10B, TNFRSF10C, TNFRSF10D | Tnfrsf10b | Alliance of Genome Resources | ||||
| cervical cancer | XRCC1* | Xrcc1 | Alliance of Genome Resources | ||||
| cervical cancer | SMAD2* | Smad2 | Alliance of Genome Resources | ||||
| cervical cancer | SF3B4* | Sf3b4 | Alliance of Genome Resources | ||||
| cervical cancer | RASSF1* | Rassf1 | Alliance of Genome Resources | ||||
| cervical cancer | NDUFS6* | Ndufs6, Ndufs6b | Alliance of Genome Resources | ||||
| cervical cancer | MTHFR* | Mthfr | Alliance of Genome Resources | ||||
| cervical cancer | MMP1* | Mmp1a, Mmp1b | Alliance of Genome Resources | ||||
| cervical cancer | MAP2K6* | Map2k6 | Alliance of Genome Resources | ||||
| cervical cancer | MAP2K3* | Map2k3 | Alliance of Genome Resources | ||||
| cervical cancer | LINC00885* | ||||||
| cervical cancer | KMT2E* | Kmt2e | Alliance of Genome Resources | ||||
| cervical cancer | KMT2A* | Kmt2a | Alliance of Genome Resources | ||||
| cervical cancer | KDM3A* | Kdm3a | Alliance of Genome Resources | ||||
| cervical cancer | HLA-B*, HLA-A, HLA-C, HLA-E, HLA-F, HLA-G, HLA-H | H2-D1, H2-K1, H2-L, H2-M1, H2-M2, H2-M3, H2-M5, H2-M9, H2-M10.1, H2-M10.2, H2-M10.3, H2-M10.4, H2-M10.5, H2-M10.6, H2-M11, H2-Q1, H2-Q2, H2-Q4, H2-Q6, H2-Q7, H2-Q8, H2-Q10, H2-T3, H2-T10, H2-T22, H2-T23 | Alliance of Genome Resources | ||||
| cervical cancer | GSTT1* | Gstt1 | Alliance of Genome Resources | ||||
| cervical cancer | GSTM1*, GSTM5 | Gstm1, Gstm2, Gstm3, Gstm6 | Alliance of Genome Resources | ||||
| cervical cancer | FANCA* | Fanca | Alliance of Genome Resources | ||||
| cervical cancer | CDK1* | Cdk1 | Alliance of Genome Resources | ||||
| cervical cancer | CDH13* | Cdh13 | Alliance of Genome Resources | ||||
| cervical cancer | CDC25A* | Cdc25a | Alliance of Genome Resources | ||||
| cervical cancer | APEX1* | Apex1 | Alliance of Genome Resources | ||||
| cervical cancer | BRCA1* | Brca1 | Alliance of Genome Resources | ||||
| cervical cancer | TP73* | Trp73 | Alliance of Genome Resources | ||||
| cervical cancer | TNF* | Tnf | Alliance of Genome Resources | ||||
| cervical cancer | TAP2* | Tap2 | Alliance of Genome Resources | ||||
| cervical cancer | HLA-DQB1*, HLA-DQB2 | H2-Ab1 | Alliance of Genome Resources | ||||
| cervical cancer | IL1B* | Il1b | Alliance of Genome Resources | ||||
| cervical cancer | HLA-DPB1* | ||||||
| cervical mucinous adenocarcinoma | STK11* | Stk11 | Alliance of Genome Resources | ||||
| cervix carcinoma | SPARC* | Sparc | Alliance of Genome Resources | ||||
| cervix carcinoma | ERAP1* | Erap1 | Alliance of Genome Resources | ||||
| cervix carcinoma | FGFR3* | Fgfr3 | Alliance of Genome Resources | ||||
| cervix carcinoma | BAK1* | Bak1 | Alliance of Genome Resources | ||||
| cervix carcinoma | APEX1* | Apex1 | Alliance of Genome Resources | ||||
| cervix carcinoma | GSTM1*, GSTM5 | Gstm1, Gstm2, Gstm3, Gstm6 | Alliance of Genome Resources | ||||
| cervix carcinoma | GSTT1* | Gstt1 | Alliance of Genome Resources | ||||
| cervix carcinoma | MGMT* | Mgmt | Alliance of Genome Resources | ||||
| cervix carcinoma | TAP2* | Tap2 | Alliance of Genome Resources | ||||
| cervix carcinoma | TSG101* | Tsg101 | Alliance of Genome Resources | ||||
| cervix uteri carcinoma in situ | HLA-DRB1*, HLA-DRB3, HLA-DRB4, HLA-DRB5 | H2-Eb1, H2-Eb2 | Alliance of Genome Resources | ||||
| cervix uteri carcinoma in situ | THRB* | Thrb | Alliance of Genome Resources | ||||
| cervix uteri carcinoma in situ | TERC* | ||||||
| cervix uteri carcinoma in situ | IL1B* | Il1b | Alliance of Genome Resources | ||||
| cervix uteri carcinoma in situ | BRCA1* | Brca1 | Alliance of Genome Resources | ||||
| cervix uteri carcinoma in situ | CDH1* | Cdh1 | Alliance of Genome Resources | ||||
| cervix uteri carcinoma in situ | CDKN2A* | Cdkn2a | Alliance of Genome Resources | ||||
| chorioamnionitis | MBL2* | Mbl2 | Alliance of Genome Resources | ||||
| chorioamnionitis | TNF* | Tnf | Alliance of Genome Resources | ||||
| chorioamnionitis | LTA* | Lta | Alliance of Genome Resources | ||||
| choriocarcinoma | IGF2* | Igf2 | Alliance of Genome Resources | ||||
| choriocarcinoma | INSR* | Insr | Alliance of Genome Resources | ||||
| chronic cervicitis | IL32* | ||||||
| congenital bilateral absence of vas deferens | CFTR* | Cftr | Alliance of Genome Resources | ||||
| dysgerminoma | KIT* | Kit | Alliance of Genome Resources | ||||
| dysgerminoma | FGFR2* | Fgfr2 | Alliance of Genome Resources | ||||
| endometrial adenocarcinoma | MAPK3* | Mapk3 | Alliance of Genome Resources | ||||
| endometrial adenocarcinoma | MAPK1* | Mapk1 | Alliance of Genome Resources | ||||
| endometrial adenocarcinoma | AXIN2* | Axin2 | Alliance of Genome Resources | ||||
| endometrial adenocarcinoma | ARID1A* | Arid1a | Alliance of Genome Resources | ||||
| endometrial adenocarcinoma | TP53* | Trp53 | Alliance of Genome Resources | ||||
| endometrial adenocarcinoma | TSG101* | Tsg101 | Alliance of Genome Resources | ||||
| endometrial adenocarcinoma | PIK3R1* | Pik3r1 | Alliance of Genome Resources | ||||
| endometrial cancer | APC* | Apc | Alliance of Genome Resources | ||||
| endometrial cancer | AKT2* | Akt2 | Alliance of Genome Resources | ||||
| endometrial cancer | ADRB3* | Adrb3 | Alliance of Genome Resources | ||||
| endometrial cancer | UGT1A1* | Ugt1a1 | Alliance of Genome Resources | ||||
| endometrial cancer | SULT1E1* | Sult1e1 | Alliance of Genome Resources | ||||
| endometrial cancer | SULT1A1*, SULT1A2, SULT1A3, SULT1A4 | Sult1a1 | Alliance of Genome Resources | ||||
| endometrial cancer | SOCS2* | Socs2 | Alliance of Genome Resources | ||||
| endometrial cancer | SHBG* | Shbg | Alliance of Genome Resources | ||||
| endometrial cancer | RNF43* | Rnf43 | Alliance of Genome Resources | ||||
| endometrial cancer | RAD21* | Rad21 | Alliance of Genome Resources | ||||
| endometrial cancer | POLE* | Pole | Alliance of Genome Resources | ||||
| endometrial cancer | PIK3R1* | Pik3r1 | Alliance of Genome Resources | ||||
| endometrial cancer | PIK3CD* | Pik3cd | Alliance of Genome Resources | ||||
| endometrial cancer | PGM1* | Pgm1 | Alliance of Genome Resources | ||||
| endometrial cancer | MSH6* | Msh6 | Alliance of Genome Resources | ||||
| endometrial cancer | MSH3* | Msh3 | Alliance of Genome Resources | ||||
| endometrial cancer | MRE11* | Mre11a | Alliance of Genome Resources | ||||
| endometrial cancer | MLH3* | Mlh3 | Alliance of Genome Resources | ||||
| endometrial cancer | MCPH1* | Mcph1 | Alliance of Genome Resources | ||||
| endometrial cancer | LTA* | Lta | Alliance of Genome Resources | ||||
| endometrial cancer | JAK1* | Jak1 | Alliance of Genome Resources | ||||
| endometrial cancer | GHRH* | Ghrh | Alliance of Genome Resources | ||||
| endometrial cancer | EGF* | Egf | Alliance of Genome Resources | ||||
| endometrial cancer | EFEMP2* | Efemp2 | Alliance of Genome Resources | ||||
| endometrial cancer | CYP19A1* | Cyp19a1 | Alliance of Genome Resources | ||||
| endometrial cancer | CYP1A2* | Cyp1a2 | Alliance of Genome Resources | ||||
| endometrial cancer | CYP1A1* | Cyp1a1 | Alliance of Genome Resources | ||||
| endometrial cancer | COMT* | Comt | Alliance of Genome Resources | ||||
| endometrial cancer | CDH1* | Cdh1 | Alliance of Genome Resources | ||||
| endometrial cancer | CDC25C* | Cdc25c | Alliance of Genome Resources | ||||
| endometrial cancer | BST2* | Bst2 | Alliance of Genome Resources | ||||
| endometrial cancer | BRCA2* | Brca2 | Alliance of Genome Resources | ||||
| endometrial cancer | BAD* | Bad | Alliance of Genome Resources | ||||
| endometrial cancer | ATM* | Atm | Alliance of Genome Resources | ||||
| endometrial cancer | AR* | Ar | Alliance of Genome Resources | ||||
| endometrial cancer | APEX1* | Apex1 | Alliance of Genome Resources | ||||
| endometrial carcinoma | MSH3* | Msh3 | Alliance of Genome Resources | ||||
| endometrial carcinoma | PIK3R1* | Pik3r1 | Alliance of Genome Resources | ||||
| endometrial carcinoma | POLE* | Pole | Alliance of Genome Resources | ||||
| endometrial carcinoma | RASSF1* | Rassf1 | Alliance of Genome Resources | ||||
| endometrial carcinoma | HRAS* | Hras | Alliance of Genome Resources | ||||
| endometrial carcinoma | MIR152* | Mir152 | Alliance of Genome Resources | ||||
| endometrial carcinoma | BRAF* | Braf | Alliance of Genome Resources | ||||
| endometrial carcinoma | SMAD4* | Smad4 | Alliance of Genome Resources | ||||
| endometrial carcinoma | SPARC* | Sparc | Alliance of Genome Resources | ||||
| endometrial carcinoma | RUNX3* | Runx3 | Alliance of Genome Resources | ||||
| endometrial carcinoma | APC* | Apc | Alliance of Genome Resources | ||||
| endometrial carcinoma | CDH13* | Cdh13 | Alliance of Genome Resources | ||||
| endometrial hyperplasia | KRAS* | Kras | Alliance of Genome Resources | ||||
| endometrial serous adenocarcinoma | BRCA2* | Brca2 | Alliance of Genome Resources | ||||
| endometriosis | HLA-DRB1*, HLA-DRB3, HLA-DRB4, HLA-DRB5 | H2-Eb1, H2-Eb2 | Alliance of Genome Resources | ||||
| endometriosis | TNFRSF1B* | Tnfrsf1b | Alliance of Genome Resources | ||||
| endometriosis | SERPINF1* | Serpinf1 | Alliance of Genome Resources | ||||
| endometriosis | PTPN22* | Ptpn22 | Alliance of Genome Resources | ||||
| endometriosis | ESR1* | Esr1 | Alliance of Genome Resources | ||||
| endometriosis | PGR* | Pgr | 1 model | Alliance of Genome Resources | |||
| enterocele | ALDH18A1* | Aldh18a1 | Alliance of Genome Resources | ||||
| fallopian tube disease | CCR5* | Ccr5 | Alliance of Genome Resources | ||||
| gestational trophoblastic neoplasm | NLRP7*, NLRP2 | Nlrp2 | Alliance of Genome Resources | ||||
| gestational trophoblastic neoplasm | TOP6BL* | Top6bl | Alliance of Genome Resources | ||||
| gestational trophoblastic neoplasm | KHDC3L* | Khdc3 | Alliance of Genome Resources | ||||
| gestational trophoblastic neoplasm | MEI1* | Mei1 | Alliance of Genome Resources | ||||
| granulosa cell tumor | MGMT* | Mgmt | Alliance of Genome Resources | ||||
| granulosa cell tumor | FHIT* | Fhit | Alliance of Genome Resources | ||||
| granulosa cell tumor | FANCF* | Fancf | Alliance of Genome Resources | ||||
| granulosa cell tumor | VEGFA* | Vegfa | Alliance of Genome Resources | ||||
| impotence | XRCC1* | Xrcc1 | Alliance of Genome Resources | ||||
| impotence | FGF2* | Fgf2 | Alliance of Genome Resources | ||||
| Leydig cell tumor | LHCGR* | Lhcgr | Alliance of Genome Resources | ||||
| male infertility | ACTL7A* | Actl7a | Alliance of Genome Resources | ||||
| male infertility | MTHFR* | Mthfr | Alliance of Genome Resources | ||||
| oligospermia | BRDT* | Brdt | Alliance of Genome Resources | ||||
| ovarian cancer | PTEN* | Pten | 8 models | Alliance of Genome Resources | |||
| ovarian cancer | AKT1* | Akt1 | Alliance of Genome Resources | ||||
| ovarian cancer | APEX1* | Apex1 | Alliance of Genome Resources | ||||
| ovarian cancer | APOB* | Apob | Alliance of Genome Resources | ||||
| ovarian cancer | AURKA* | Aurka | Alliance of Genome Resources | ||||
| ovarian cancer | BARD1* | Bard1 | Alliance of Genome Resources | ||||
| ovarian cancer | BRCA1* | Brca1 | 2 models | Alliance of Genome Resources | |||
| ovarian cancer | BRCA2* | Brca2 | 1 model | Alliance of Genome Resources | |||
| ovarian cancer | CAMK2N1* | Camk2n1 | Alliance of Genome Resources | ||||
| ovarian cancer | CCNG1* | Ccng1 | Alliance of Genome Resources | ||||
| ovarian cancer | CD59* | Cd59a, Cd59b | Alliance of Genome Resources | ||||
| ovarian cancer | CDH1* | Cdh1 | Alliance of Genome Resources | ||||
| ovarian cancer | CDH13* | Cdh13 | Alliance of Genome Resources | ||||
| ovarian cancer | CLDN4* | Cldn4, Cldn13 | Alliance of Genome Resources | ||||
| ovarian cancer | COMT* | Comt | Alliance of Genome Resources | ||||
| ovarian cancer | CYP19A1* | Cyp19a1 | Alliance of Genome Resources | ||||
| ovarian cancer | EEF1A2* | Eef1a2 | Alliance of Genome Resources | ||||
| ovarian cancer | ERBB2* | Erbb2 | Alliance of Genome Resources | ||||
| ovarian cancer | FANCA* | Fanca | Alliance of Genome Resources | ||||
| ovarian cancer | GHRH* | Ghrh | Alliance of Genome Resources | ||||
| ovarian cancer | GSTA1*, GSTA2, GSTA3, GSTA5 | Gsta1, Gsta2, Gsta3, Gsta5, Gsta13 | Alliance of Genome Resources | ||||
| ovarian cancer | GSTP1* | Gstp1, Gstp2, Gstp3, Gstp-ps | Alliance of Genome Resources | ||||
| ovarian cancer | HFE* | Hfe | Alliance of Genome Resources | ||||
| ovarian cancer | HMGA2* | Hmga2 | Alliance of Genome Resources | ||||
| ovarian cancer | ITGA8* | Itga8 | Alliance of Genome Resources | ||||
| ovarian cancer | JAK1* | Jak1 | Alliance of Genome Resources | ||||
| ovarian cancer | JUP* | Jup | Alliance of Genome Resources | ||||
| ovarian cancer | LEF1* | Lef1 | Alliance of Genome Resources | ||||
| ovarian cancer | MBL2* | Mbl2 | Alliance of Genome Resources | ||||
| ovarian cancer | MIR1271* | ||||||
| ovarian cancer | MMP1* | Mmp1a, Mmp1b | Alliance of Genome Resources | ||||
| ovarian cancer | MSLN* | Msln | Alliance of Genome Resources | ||||
| ovarian cancer | MUC16* | Muc16 | Alliance of Genome Resources | ||||
| ovarian cancer | MYO6* | Myo6 | Alliance of Genome Resources | ||||
| ovarian cancer | NBN* | Nbn | Alliance of Genome Resources | ||||
| ovarian cancer | NOD2* | Nod2 | Alliance of Genome Resources | ||||
| ovarian cancer | NOS3* | Nos3 | Alliance of Genome Resources | ||||
| ovarian cancer | OGG1* | Ogg1 | Alliance of Genome Resources | ||||
| ovarian cancer | OIP5-AS1* | ||||||
| ovarian cancer | OPCML* | Opcml | Alliance of Genome Resources | ||||
| ovarian cancer | PIK3CA* | Pik3ca | 1 model | Alliance of Genome Resources | |||
| ovarian cancer | PMS2*, PMS2P1, PMS2P2, PMS2P6 | Pms2 | Alliance of Genome Resources | ||||
| ovarian cancer | POT1* | Pot1a, Pot1b | Alliance of Genome Resources | ||||
| ovarian cancer | PRKCA* | Prkca | Alliance of Genome Resources | ||||
| ovarian cancer | PRKN* | Prkn | Alliance of Genome Resources | ||||
| ovarian cancer | RAD51* | Rad51 | Alliance of Genome Resources | ||||
| ovarian cancer | RASSF1* | Rassf1 | Alliance of Genome Resources | ||||
| ovarian cancer | RUNX3* | Runx3 | Alliance of Genome Resources | ||||
| ovarian cancer | SMAD2* | Smad2 | Alliance of Genome Resources | ||||
| ovarian cancer | SMAD4* | Smad4 | Alliance of Genome Resources | ||||
| ovarian cancer | SOD2* | Sod2 | Alliance of Genome Resources | ||||
| ovarian cancer | STAT3* | Stat3 | Alliance of Genome Resources | ||||
| ovarian cancer | TFRC* | Tfrc | Alliance of Genome Resources | ||||
| ovarian cancer | UGT1A1* | Ugt1a1 | Alliance of Genome Resources | ||||
| ovarian cancer | WRAP53* | Wrap53 | Alliance of Genome Resources | ||||
| ovarian carcinoma | MMP13* | Mmp13 | Alliance of Genome Resources | ||||
| ovarian carcinoma | STK11* | Stk11 | Alliance of Genome Resources | ||||
| ovarian carcinoma | SOCS2* | Socs2 | Alliance of Genome Resources | ||||
| ovarian carcinoma | MAP2K6* | Map2k6 | Alliance of Genome Resources | ||||
| ovarian carcinoma | MIR23B* | Mir23b | Alliance of Genome Resources | ||||
| ovarian carcinoma | CYTB* | mt-Cytb | Alliance of Genome Resources | ||||
| ovarian carcinoma | AKT2* | Akt2 | Alliance of Genome Resources | ||||
| ovarian carcinoma | AMH* | Amh | Alliance of Genome Resources | ||||
| ovarian carcinoma | CABIN1* | Cabin1 | Alliance of Genome Resources | ||||
| ovarian carcinoma | CAMK2N1* | Camk2n1 | Alliance of Genome Resources | ||||
| ovarian carcinoma | CASP6* | Casp6 | Alliance of Genome Resources | ||||
| ovarian carcinoma | CCND1* | Ccnd1 | Alliance of Genome Resources | ||||
| ovarian carcinoma | CCNG1* | Ccng1 | Alliance of Genome Resources | ||||
| ovarian carcinoma | SOCS1* | Socs1 | Alliance of Genome Resources | ||||
| ovarian carcinoma | L1CAM* | L1cam | Alliance of Genome Resources | ||||
| ovarian clear cell carcinoma | ARID1A* | Arid1a | Alliance of Genome Resources | ||||
| ovarian endometrial cancer | ARHGEF10L* | Arhgef10l | Alliance of Genome Resources | ||||
| ovarian hyperstimulation syndrome | FSHR* | Fshr | Alliance of Genome Resources | ||||
| ovarian hyperstimulation syndrome | SERPINF1* | Serpinf1 | Alliance of Genome Resources | ||||
| ovarian serous carcinoma | ARHGEF10L* | Arhgef10l | Alliance of Genome Resources | ||||
| ovarian serous carcinoma | MAP2K4* | Map2k4 | Alliance of Genome Resources | ||||
| ovary epithelial cancer | NME1* | Nme1 | Alliance of Genome Resources | ||||
| ovary epithelial cancer | AKAP6* | Akap6 | Alliance of Genome Resources | ||||
| ovary epithelial cancer | CCR3* | Ccr3 | Alliance of Genome Resources | ||||
| ovary epithelial cancer | TAB2* | Tab2 | Alliance of Genome Resources | ||||
| ovary epithelial cancer | KIF1B* | Kif1b | Alliance of Genome Resources | ||||
| ovary epithelial cancer | H19* | ||||||
| ovary epithelial cancer | GSTT1* | Gstt1 | Alliance of Genome Resources | ||||
| ovary epithelial cancer | GSTM1*, GSTM5 | Gstm1, Gstm2, Gstm3, Gstm6 | Alliance of Genome Resources | ||||
| ovary epithelial cancer | ERCC2* | Ercc2 | Alliance of Genome Resources | ||||
| ovary epithelial cancer | ERCC1* | Ercc1 | Alliance of Genome Resources | ||||
| ovary epithelial cancer | DAXX* | Daxx | Alliance of Genome Resources | ||||
| ovary serous adenocarcinoma | TP53* | Trp53 | Alliance of Genome Resources | ||||
| persistent Mullerian duct syndrome | AMH* | Amh | Alliance of Genome Resources | ||||
| placental abruption | PROC* | Proc | Alliance of Genome Resources | ||||
| placental insufficiency | EPO* | Epo | Alliance of Genome Resources | ||||
| polycystic ovary syndrome | VDR* | Vdr | Alliance of Genome Resources | ||||
| polycystic ovary syndrome | CYP19A1* | Cyp19a1 | Alliance of Genome Resources | ||||
| polycystic ovary syndrome | CYP1A1* | Cyp1a1 | Alliance of Genome Resources | ||||
| polycystic ovary syndrome | CAPN10* | Capn10 | Alliance of Genome Resources | ||||
| polycystic ovary syndrome | FST* | Fst | Alliance of Genome Resources | ||||
| premature menopause | POLG* | Polg | Alliance of Genome Resources | ||||
| preterm premature rupture of the membranes | SERPINH1* | Serpinh1 | Alliance of Genome Resources | ||||
| priapism | F13A1* | F13a1 | Alliance of Genome Resources | ||||
| primary ovarian insufficiency | BBS9* | Bbs9 | Alliance of Genome Resources | ||||
| primary ovarian insufficiency | BMP15* | Bmp15 | Alliance of Genome Resources | ||||
| primary ovarian insufficiency | DIAPH2* | Diaph2 | Alliance of Genome Resources | ||||
| primary ovarian insufficiency | FANCA* | Fanca | Alliance of Genome Resources | ||||
| primary ovarian insufficiency | KASH5* | Kash5 | Alliance of Genome Resources | ||||
| primary ovarian insufficiency | MEIOB* | Meiob | Alliance of Genome Resources | ||||
| primary ovarian insufficiency | MSH4* | Msh4 | Alliance of Genome Resources | ||||
| primary ovarian insufficiency | POLG* | Polg | Alliance of Genome Resources | ||||
| primary ovarian insufficiency | TP63* | Trp63 | Alliance of Genome Resources | ||||
| primary ovarian insufficiency | XPO5* | Xpo5 | Alliance of Genome Resources | ||||
| primary ovarian insufficiency 1 | FMR1* | Fmr1 | Alliance of Genome Resources | ||||
| primary ovarian insufficiency 10 | MCM8* | Mcm8 | Alliance of Genome Resources | ||||
| primary ovarian insufficiency 11 | ERCC6* | Ercc6 | Alliance of Genome Resources | ||||
| primary ovarian insufficiency 14 | GDF9* | Gdf9 | Alliance of Genome Resources | ||||
| primary ovarian insufficiency 15 | FANCM* | Fancm | Alliance of Genome Resources | ||||
| primary ovarian insufficiency 16 | BNC1* | Bnc1 | Alliance of Genome Resources | ||||
| primary ovarian insufficiency 17 | XRCC2* | Xrcc2 | Alliance of Genome Resources | ||||
| primary ovarian insufficiency 18 | C14orf39* | 4930447C04Rik | Alliance of Genome Resources | ||||
| primary ovarian insufficiency 2A | DIAPH2* | Diaph2 | Alliance of Genome Resources | ||||
| primary ovarian insufficiency 2B | POF1B* | Pof1b | Alliance of Genome Resources | ||||
| primary ovarian insufficiency 3 | FOXL2* | Foxl2 | Alliance of Genome Resources | ||||
| primary ovarian insufficiency 5 | NOBOX* | Nobox | Alliance of Genome Resources | ||||
| primary ovarian insufficiency 6 | FIGLA* | Figla | Alliance of Genome Resources | ||||
| primary ovarian insufficiency 7 | NR5A1* | Nr5a1 | Alliance of Genome Resources | ||||
| primary ovarian insufficiency 8 | STAG3* | Stag3 | Alliance of Genome Resources | ||||
| primary ovarian insufficiency 9 | HFM1* | Hfm1 | Alliance of Genome Resources | ||||
| prostate adenocarcinoma | MAPK1* | Mapk1 | Alliance of Genome Resources | ||||
| prostate adenocarcinoma | INSR* | Insr | Alliance of Genome Resources | ||||
| prostate adenocarcinoma | PIK3CB* | Pik3cb | Alliance of Genome Resources | ||||
| prostate adenocarcinoma | IKBKB* | Ikbkb | Alliance of Genome Resources | ||||
| prostate adenocarcinoma | IGF1R* | Igf1r | Alliance of Genome Resources | ||||
| prostate adenocarcinoma | GRB2* | Grb2 | Alliance of Genome Resources | ||||
| prostate adenocarcinoma | FGF2* | Fgf2 | Alliance of Genome Resources | ||||
| prostate adenocarcinoma | CD9* | Cd9 | Alliance of Genome Resources | ||||
| prostate adenocarcinoma | CAMK2N1* | Camk2n1 | Alliance of Genome Resources | ||||
| prostate adenocarcinoma | BRAF* | Braf | Alliance of Genome Resources | ||||
| prostate adenocarcinoma | MYC* | Bmyc, Myc | Alliance of Genome Resources | ||||
| prostate adenocarcinoma | BIN1* | Bin1 | Alliance of Genome Resources | ||||
| prostate adenocarcinoma | AKT3* | Akt3 | Alliance of Genome Resources | ||||
| prostate adenocarcinoma | AKT2* | Akt2 | Alliance of Genome Resources | ||||
| prostate adenocarcinoma | AKT1* | Akt1 | Alliance of Genome Resources | ||||
| prostate adenocarcinoma | ADIPOR1* | Adipor1 | Alliance of Genome Resources | ||||
| prostate adenocarcinoma | ADIPOQ* | Adipoq | Alliance of Genome Resources | ||||
| prostate adenocarcinoma | STAT1* | Stat1 | Alliance of Genome Resources | ||||
| prostate adenocarcinoma | RAF1* | Raf1 | Alliance of Genome Resources | ||||
| prostate adenocarcinoma | NCOA2* | Ncoa2 | Alliance of Genome Resources | ||||
| prostate cancer | TERC* | ||||||
| prostate cancer | ACSL3* | Acsl3 | Alliance of Genome Resources | ||||
| prostate cancer | AGAP2* | Agap2 | Alliance of Genome Resources | ||||
| prostate cancer | AKT1* | Akt1 | Alliance of Genome Resources | ||||
| prostate cancer | AKT2* | Akt2 | Alliance of Genome Resources | ||||
| prostate cancer | AKT3* | Akt3 | Alliance of Genome Resources | ||||
| prostate cancer | ANG* | Ang, Ang2, Ang3, Ang4, Ang5, Ang6 | Alliance of Genome Resources | ||||
| prostate cancer | AR* | Ar | 4 models | Alliance of Genome Resources | |||
| prostate cancer | BAG1* | Bag1 | Alliance of Genome Resources | ||||
| prostate cancer | BCL2* | Bcl2 | Alliance of Genome Resources | ||||
| prostate cancer | BGLAP* | Bglap, Bglap2, Bglap3 | Alliance of Genome Resources | ||||
| prostate cancer | BIK* | Bik | Alliance of Genome Resources | ||||
| prostate cancer | BIRC5* | Birc5 | Alliance of Genome Resources | ||||
| prostate cancer | BMP2* | Bmp2 | Alliance of Genome Resources | ||||
| prostate cancer | BMP7* | Bmp7 | Alliance of Genome Resources | ||||
| prostate cancer | MYC* | Bmyc, Myc | Alliance of Genome Resources | ||||
| prostate cancer | BRCA1* | Brca1 | Alliance of Genome Resources | ||||
| prostate cancer | BRCA2* | Brca2 | 1 model | Alliance of Genome Resources | |||
| prostate cancer | CADM1* | Cadm1 | Alliance of Genome Resources | ||||
| prostate cancer | CAV1* | Cav1 | Alliance of Genome Resources | ||||
| prostate cancer | CCNA1* | Ccna1 | Alliance of Genome Resources | ||||
| prostate cancer | CCNB1* | Ccnb1, Ccnb1-ps | Alliance of Genome Resources | ||||
| prostate cancer | CCND2* | Ccnd2 | Alliance of Genome Resources | ||||
| prostate cancer | CD44* | Cd44 | Alliance of Genome Resources | ||||
| prostate cancer | CD55* | Cd55, Cd55b | Alliance of Genome Resources | ||||
| prostate cancer | CDC25A* | Cdc25a | Alliance of Genome Resources | ||||
| prostate cancer | CDC25C* | Cdc25c | Alliance of Genome Resources | ||||
| prostate cancer | CDH1* | Cdh1 | Alliance of Genome Resources | ||||
| prostate cancer | CDH13* | Cdh13 | Alliance of Genome Resources | ||||
| prostate cancer | CDK2* | Cdk2 | Alliance of Genome Resources | ||||
| prostate cancer | CDK4* | Cdk4 | Alliance of Genome Resources | ||||
| prostate cancer | CDKN2A* | Cdkn2a | 1 model | Alliance of Genome Resources | |||
| prostate cancer | CHD1* | Chd1 | Alliance of Genome Resources | ||||
| prostate cancer | CHEK2* | Chek2 | Alliance of Genome Resources | ||||
| prostate cancer | CHGA* | Chga | Alliance of Genome Resources | ||||
| prostate cancer | CHUK* | Chuk | Alliance of Genome Resources | ||||
| prostate cancer | COMT* | Comt | Alliance of Genome Resources | ||||
| prostate cancer | CXCR4* | Cxcr4 | Alliance of Genome Resources | ||||
| prostate cancer | CYP1A1* | Cyp1a1 | Alliance of Genome Resources | ||||
| prostate cancer | CYP17A1* | Cyp17a1 | Alliance of Genome Resources | ||||
| prostate cancer | DAB2IP* | Dab2ip | Alliance of Genome Resources | ||||
| prostate cancer | EGFR* | Egfr | Alliance of Genome Resources | ||||
| prostate cancer | EIF3H* | Eif3h | Alliance of Genome Resources | ||||
| prostate cancer | ENO2* | Eno2 | Alliance of Genome Resources | ||||
| prostate cancer | EPHB1* | Ephb1 | Alliance of Genome Resources | ||||
| prostate cancer | ERBB2* | Erbb2 | Alliance of Genome Resources | ||||
| prostate cancer | ERCC2* | Ercc2 | Alliance of Genome Resources | ||||
| prostate cancer | ESR1* | Esr1 | Alliance of Genome Resources | ||||
| prostate cancer | ESR2* | Esr2 | Alliance of Genome Resources | ||||
| prostate cancer | FAS* | Fas | Alliance of Genome Resources | ||||
| prostate cancer | FGFR4* | Fgfr4 | Alliance of Genome Resources | ||||
| prostate cancer | FHIT* | Fhit | Alliance of Genome Resources | ||||
| prostate cancer | FLT3* | Flt3 | Alliance of Genome Resources | ||||
| prostate cancer | GRB2* | Grb2 | Alliance of Genome Resources | ||||
| prostate cancer | GSTM1*, GSTM5 | Gstm1, Gstm2, Gstm3, Gstm6 | Alliance of Genome Resources | ||||
| prostate cancer | GSTP1* | Gstp1, Gstp2, Gstp3, Gstp-ps | Alliance of Genome Resources | ||||
| prostate cancer | GSTT1* | Gstt1 | Alliance of Genome Resources | ||||
| prostate cancer | HLA-DRB1*, HLA-DRB3, HLA-DRB4, HLA-DRB5 | H2-Eb1, H2-Eb2 | Alliance of Genome Resources | ||||
| prostate cancer | HIF1A* | Hif1a | Alliance of Genome Resources | ||||
| prostate cancer | ICAM1* | Icam1 | Alliance of Genome Resources | ||||
| prostate cancer | IGFBP3* | Igfbp3 | Alliance of Genome Resources | ||||
| prostate cancer | IKBKB* | Ikbkb | Alliance of Genome Resources | ||||
| prostate cancer | IL16* | Il16 | Alliance of Genome Resources | ||||
| prostate cancer | JAK1* | Jak1 | Alliance of Genome Resources | ||||
| prostate cancer | JUP* | Jup | Alliance of Genome Resources | ||||
| prostate cancer | KIF5A* | Kif5a | Alliance of Genome Resources | ||||
| prostate cancer | KLF6* | Klf6 | Alliance of Genome Resources | ||||
| prostate cancer | KLK4* | Klk4 | Alliance of Genome Resources | ||||
| prostate cancer | KLK10* | Klk10 | Alliance of Genome Resources | ||||
| prostate cancer | LIG4* | Lig4 | Alliance of Genome Resources | ||||
| prostate cancer | LINC01595* | ||||||
| prostate cancer | MAD1L1* | Mad1l1 | Alliance of Genome Resources | ||||
| prostate cancer | MAP3K7* | Map3k7 | Alliance of Genome Resources | ||||
| prostate cancer | MIR615* | Mir615 | Alliance of Genome Resources | ||||
| prostate cancer | MSR1* | Msr1 | Alliance of Genome Resources | ||||
| prostate cancer | MTOR* | Mtor | Alliance of Genome Resources | ||||
| prostate cancer | MX1*, MX2 | Mx1, Mx2 | Alliance of Genome Resources | ||||
| prostate cancer | MXI1* | Mxi1 | Alliance of Genome Resources | ||||
| prostate cancer | NAT1*, NAT2* | Nat1, Nat2, Nat3 | Alliance of Genome Resources | ||||
| prostate cancer | NBN* | Nbn | Alliance of Genome Resources | ||||
| prostate cancer | NFKB1* | Nfkb1 | Alliance of Genome Resources | ||||
| prostate cancer | NFKBIA* | Nfkbia | Alliance of Genome Resources | ||||
| prostate cancer | NOS3* | Nos3 | Alliance of Genome Resources | ||||
| prostate cancer | OGG1* | Ogg1 | Alliance of Genome Resources | ||||
| prostate cancer | PEBP1* | Pbp2, Pebp1 | Alliance of Genome Resources | ||||
| prostate cancer | PDPK1*, PDPK2P | Pdpk1 | Alliance of Genome Resources | ||||
| prostate cancer | PIK3CB* | Pik3cb | Alliance of Genome Resources | ||||
| prostate cancer | PTGS2* | Ptgs2 | Alliance of Genome Resources | ||||
| prostate cancer | RASSF1* | Rassf1 | Alliance of Genome Resources | ||||
| prostate cancer | RB1* | Rb1 | Alliance of Genome Resources | ||||
| prostate cancer | RNASEL* | Rnasel | Alliance of Genome Resources | ||||
| prostate cancer | RTEL1* | Rtel1 | Alliance of Genome Resources | ||||
| prostate cancer | SOCS1* | Socs1 | Alliance of Genome Resources | ||||
| prostate cancer | SRC* | Src | Alliance of Genome Resources | ||||
| prostate cancer | SRD5A1* | Srd5a1 | Alliance of Genome Resources | ||||
| prostate cancer | SRD5A2* | Srd5a2 | Alliance of Genome Resources | ||||
| prostate cancer | SREBF2* | Srebf2 | Alliance of Genome Resources | ||||
| prostate cancer | STAT3* | Stat3 | Alliance of Genome Resources | ||||
| prostate cancer | SULT1A1*, SULT1A2, SULT1A3, SULT1A4 | Sult1a1 | Alliance of Genome Resources | ||||
| prostate cancer | SULT2A1* | Sult2a1, Sult2a2, Sult2a3, Sult2a4, Sult2a5, Sult2a6, Sult2a7, Sult2a8 | Alliance of Genome Resources | ||||
| prostate cancer | TCF7L2* | Tcf7l2 | Alliance of Genome Resources | ||||
| prostate cancer | THRB* | Thrb | Alliance of Genome Resources | ||||
| prostate cancer | TLR2* | Tlr2 | Alliance of Genome Resources | ||||
| prostate cancer | TMEFF2* | Tmeff2 | Alliance of Genome Resources | ||||
| prostate cancer | TNF* | Tnf | Alliance of Genome Resources | ||||
| prostate cancer | TP53* | Trp53 | 2 models | Alliance of Genome Resources | |||
| prostate cancer | TSG101* | Tsg101 | Alliance of Genome Resources | ||||
| prostate cancer | TSPY1* | ||||||
| prostate cancer | VDAC1* | Vdac1 | Alliance of Genome Resources | ||||
| prostate cancer | VDR* | Vdr | Alliance of Genome Resources | ||||
| prostate cancer | VEGFA* | Vegfa | Alliance of Genome Resources | ||||
| prostate cancer | XIAP*, BIRC8 | Xiap | Alliance of Genome Resources | ||||
| prostate cancer | XRCC1* | Xrcc1 | Alliance of Genome Resources | ||||
| prostate cancer | ZFHX3* | Zfhx3 | Alliance of Genome Resources | ||||
| prostate carcinoma | STAT6* | Stat6 | Alliance of Genome Resources | ||||
| prostate carcinoma | E2F5* | E2f5 | Alliance of Genome Resources | ||||
| prostate carcinoma | CDK13* | Cdk13 | Alliance of Genome Resources | ||||
| prostate carcinoma | BCL2L1* | Bcl2l1 | Alliance of Genome Resources | ||||
| prostate carcinoma | AZGP1* | Azgp1 | Alliance of Genome Resources | ||||
| prostate carcinoma | ATF4* | Atf4 | Alliance of Genome Resources | ||||
| prostate carcinoma | AKT2* | Akt2 | Alliance of Genome Resources | ||||
| prostate carcinoma | INHA* | Inha | Alliance of Genome Resources | ||||
| prostate carcinoma | EIF3H* | Eif3h | Alliance of Genome Resources | ||||
| prostate carcinoma | PRKCA* | Prkca | Alliance of Genome Resources | ||||
| prostate carcinoma | SKP2* | Skp2 | Alliance of Genome Resources | ||||
| prostate carcinoma | SPP1* | Spp1 | Alliance of Genome Resources | ||||
| prostate carcinoma | STAT3* | Stat3 | Alliance of Genome Resources | ||||
| prostate carcinoma in situ | FGF8* | Fgf8 | Alliance of Genome Resources | ||||
| prostate carcinoma in situ | CYP19A1* | Cyp19a1 | Alliance of Genome Resources | ||||
| prostatic hypertrophy | PDGFB* | Pdgfb | Alliance of Genome Resources | ||||
| prostatic hypertrophy | SRD5A1* | Srd5a1 | Alliance of Genome Resources | ||||
| prostatic hypertrophy | PDGFD* | Pdgfd | Alliance of Genome Resources | ||||
| prostatitis | CYP19A1* | Cyp19a1 | Alliance of Genome Resources | ||||
| spermatogenic failure 1 | SYCP2* | Sycp2 | Alliance of Genome Resources | ||||
| spermatogenic failure 10 | SEPTIN12* | Septin12 | Alliance of Genome Resources | ||||
| spermatogenic failure 11 | KLHL10* | Klhl10 | Alliance of Genome Resources | ||||
| spermatogenic failure 12 | NANOS1* | Nanos1 | Alliance of Genome Resources | ||||
| spermatogenic failure 13 | TAF4B* | Taf4b | Alliance of Genome Resources | ||||
| spermatogenic failure 14 | ZMYND15* | Zmynd15 | Alliance of Genome Resources | ||||
| spermatogenic failure 15 | SYCE1* | Syce1 | Alliance of Genome Resources | ||||
| spermatogenic failure 16 | SUN5* | Sun5 | Alliance of Genome Resources | ||||
| spermatogenic failure 17 | PLCZ1* | Plcz1 | Alliance of Genome Resources | ||||
| spermatogenic failure 18 | DNAH1* | Dnah1 | Alliance of Genome Resources | ||||
| spermatogenic failure 2 | MSH4* | Msh4 | Alliance of Genome Resources | ||||
| spermatogenic failure 21 | BRDT* | Brdt | Alliance of Genome Resources | ||||
| spermatogenic failure 22 | MEIOB* | Meiob | Alliance of Genome Resources | ||||
| spermatogenic failure 23 | TEX14* | Tex14 | Alliance of Genome Resources | ||||
| spermatogenic failure 25 | TEX15* | Tex15 | Alliance of Genome Resources | ||||
| spermatogenic failure 26 | TSGA10* | Tsga10 | Alliance of Genome Resources | ||||
| spermatogenic failure 27 | AK7* | Ak7 | Alliance of Genome Resources | ||||
| spermatogenic failure 28 | FANCM* | Fancm | Alliance of Genome Resources | ||||
| spermatogenic failure 29 | SPINK2* | Spink2 | Alliance of Genome Resources | ||||
| spermatogenic failure 3 | SRSF6* | Srsf6 | Alliance of Genome Resources | ||||
| spermatogenic failure 3 | SLC26A8* | Slc26a8 | Alliance of Genome Resources | ||||
| spermatogenic failure 30 | TDRD9* | Tdrd9 | Alliance of Genome Resources | ||||
| spermatogenic failure 32 | SOHLH1* | Sohlh1 | Alliance of Genome Resources | ||||
| spermatogenic failure 33 | CFAP251* | Cfap251 | Alliance of Genome Resources | ||||
| spermatogenic failure 34 | FSIP2* | Fsip2 | Alliance of Genome Resources | ||||
| spermatogenic failure 35 | QRICH2* | Qrich2 | Alliance of Genome Resources | ||||
| spermatogenic failure 36 | PPP2R3C* | Ppp2r3c | Alliance of Genome Resources | ||||
| spermatogenic failure 37 | TTC21A* | Ttc21a | Alliance of Genome Resources | ||||
| spermatogenic failure 38 | ARMC2* | Armc2 | Alliance of Genome Resources | ||||
| spermatogenic failure 4 | SYCP3* | Gm773, Sycp3 | Alliance of Genome Resources | ||||
| spermatogenic failure 41 | CFAP70* | Cfap70 | Alliance of Genome Resources | ||||
| spermatogenic failure 42 | TTC29* | Ttc29 | Alliance of Genome Resources | ||||
| spermatogenic failure 43 | SPEF2* | Spef2 | Alliance of Genome Resources | ||||
| spermatogenic failure 44 | CEP112* | Cep112 | Alliance of Genome Resources | ||||
| spermatogenic failure 45 | DNAH2* | Dnah2 | Alliance of Genome Resources | ||||
| spermatogenic failure 48 | M1AP* | M1ap | Alliance of Genome Resources | ||||
| spermatogenic failure 49 | CFAP58* | Cfap58 | Alliance of Genome Resources | ||||
| spermatogenic failure 5 | AURKC* | Aurkc | Alliance of Genome Resources | ||||
| spermatogenic failure 50 | XRCC2* | Xrcc2 | Alliance of Genome Resources | ||||
| spermatogenic failure 51 | CFAP91* | Cfap91 | Alliance of Genome Resources | ||||
| spermatogenic failure 52 | C14orf39* | 4930447C04Rik | Alliance of Genome Resources | ||||
| spermatogenic failure 53 | ACTL9* | Actl9 | Alliance of Genome Resources | ||||
| spermatogenic failure 54 | CATIP* | Catip | Alliance of Genome Resources | ||||
| spermatogenic failure 55 | SPAG17* | Spag17 | Alliance of Genome Resources | ||||
| spermatogenic failure 56 | DNAH10* | Dnah10 | Alliance of Genome Resources | ||||
| spermatogenic failure 57 | PNLDC1* | Pnldc1 | Alliance of Genome Resources | ||||
| spermatogenic failure 58 | IFT74* | Ift74 | Alliance of Genome Resources | ||||
| spermatogenic failure 59 | TERB2* | Terb2 | Alliance of Genome Resources | ||||
| spermatogenic failure 6 | SPATA16* | Spata16 | Alliance of Genome Resources | ||||
| spermatogenic failure 60 | TERB1* | Terb1 | Alliance of Genome Resources | ||||
| spermatogenic failure 61 | STAG3* | Stag3 | Alliance of Genome Resources | ||||
| spermatogenic failure 62 | RNF212* | Rnf212 | Alliance of Genome Resources | ||||
| spermatogenic failure 63 | RPL10L* | Rpl10l | Alliance of Genome Resources | ||||
| spermatogenic failure 64 | FBXO43* | Fbxo43 | Alliance of Genome Resources | ||||
| spermatogenic failure 65 | DNHD1* | Dnhd1 | Alliance of Genome Resources | ||||
| spermatogenic failure 66 | ZPBP* | Zpbp | Alliance of Genome Resources | ||||
| spermatogenic failure 67 | CCDC62* | Ccdc62 | Alliance of Genome Resources | ||||
| spermatogenic failure 68 | C2CD6* | C2cd6 | Alliance of Genome Resources | ||||
| spermatogenic failure 69 | GGN* | Ggn | Alliance of Genome Resources | ||||
| spermatogenic failure 7 | CATSPER1* | Catsper1 | Alliance of Genome Resources | ||||
| spermatogenic failure 70 | PDHA2* | Pdha2 | Alliance of Genome Resources | ||||
| spermatogenic failure 71 | ZSWIM7* | Zswim7 | Alliance of Genome Resources | ||||
| spermatogenic failure 72 | WDR19* | Wdr19 | Alliance of Genome Resources | ||||
| spermatogenic failure 73 | MOV10L1* | Mov10l1 | Alliance of Genome Resources | ||||
| spermatogenic failure 74 | MSH5* | Msh5 | Alliance of Genome Resources | ||||
| spermatogenic failure 75 | SHOC1* | Shoc1 | Alliance of Genome Resources | ||||
| spermatogenic failure 76 | CCDC34* | Ccdc34 | Alliance of Genome Resources | ||||
| spermatogenic failure 77 | FKBP6* | Fkbp6 | Alliance of Genome Resources | ||||
| spermatogenic failure 78 | IQCN* | Iqcn | Alliance of Genome Resources | ||||
| spermatogenic failure 79 | KCNU1* | Kcnu1 | Alliance of Genome Resources | ||||
| spermatogenic failure 8 | NR5A1* | Nr5a1 | Alliance of Genome Resources | ||||
| spermatogenic failure 80 | DRC1* | Drc1 | Alliance of Genome Resources | ||||
| spermatogenic failure 81 | TEKT3* | Tekt3 | Alliance of Genome Resources | ||||
| spermatogenic failure 82 | AKAP3* | Akap3 | Alliance of Genome Resources | ||||
| spermatogenic failure 83 | DNALI1* | Dnali1 | Alliance of Genome Resources | ||||
| spermatogenic failure 84 | CFAP61* | Cfap61 | Alliance of Genome Resources | ||||
| spermatogenic failure 85 | SPACA1* | Spaca1 | Alliance of Genome Resources | ||||
| spermatogenic failure 86 | ACTL7A* | Actl7a | Alliance of Genome Resources | ||||
| spermatogenic failure 87 | ACR* | Acr | Alliance of Genome Resources | ||||
| spermatogenic failure 88 | KASH5* | Kash5 | Alliance of Genome Resources | ||||
| spermatogenic failure 89 | AK9* | Ak9 | Alliance of Genome Resources | ||||
| spermatogenic failure 9 | DPY19L2*, DPY19L2P1, DPY19L2P2 | Dpy19l2 | Alliance of Genome Resources | ||||
| spermatogenic failure 90 | ARMC12* | Armc12 | Alliance of Genome Resources | ||||
| spermatogenic failure 91 | CCIN* | Ccin | Alliance of Genome Resources | ||||
| spermatogenic failure 92 | LRRC23* | Lrrc23 | Alliance of Genome Resources | ||||
| spermatogenic failure 93 | STK33* | Stk33 | Alliance of Genome Resources | ||||
| spermatogenic failure 94 | CCDC146* | Ccdc146 | Alliance of Genome Resources | ||||
| spermatogenic failure 95 | CFAP57* | Cfap57 | Alliance of Genome Resources | ||||
| subserous uterine fibroid | TNRC6B* | Tnrc6b | Alliance of Genome Resources | ||||
| testicular cancer | GSTP1* | Gstp1, Gstp2, Gstp3, Gstp-ps | Alliance of Genome Resources | ||||
| testicular lymphoma | MYD88* | Myd88 | Alliance of Genome Resources | ||||
| uterine cancer | AURKA* | Aurka | Alliance of Genome Resources | ||||
| uterine fibroid | IRS1* | Irs1 | Alliance of Genome Resources | ||||
| uterine fibroid | ADA* | Ada | Alliance of Genome Resources | ||||
| uterine fibroid | BET1L* | Bet1l | Alliance of Genome Resources | ||||
| uterine fibroid | COL4A1* | Col4a1 | Alliance of Genome Resources | ||||
| uterine fibroid | COL4A2* | Col4a2 | Alliance of Genome Resources | ||||
| uterine fibroid | COL6A3* | Col6a3 | Alliance of Genome Resources | ||||
| uterine fibroid | DAPK1* | Dapk1 | Alliance of Genome Resources | ||||
| uterine fibroid | GSTM5*, GSTM1 | Gstm1, Gstm2, Gstm3, Gstm6 | Alliance of Genome Resources | ||||
| uterine fibroid | NUAK1* | Nuak1 | Alliance of Genome Resources | ||||
| uterine fibroid | TNRC6B* | Tnrc6b | Alliance of Genome Resources | ||||
| vulva cancer | NOS3* | Nos3 | Alliance of Genome Resources | ||||
| vulva cancer | HLA-A*, HLA-B, HLA-C, HLA-E, HLA-F, HLA-G, HLA-H | H2-D1, H2-K1, H2-L, H2-M1, H2-M2, H2-M3, H2-M5, H2-M9, H2-M10.1, H2-M10.2, H2-M10.3, H2-M10.4, H2-M10.5, H2-M10.6, H2-M11, H2-Q1, H2-Q2, H2-Q4, H2-Q6, H2-Q7, H2-Q8, H2-Q10, H2-T3, H2-T10, H2-T22, H2-T23 | Alliance of Genome Resources | ||||
| vulva cancer | HLA-DRB1*, HLA-DRB3, HLA-DRB4, HLA-DRB5 | H2-Eb1, H2-Eb2 | Alliance of Genome Resources | ||||
| vulva cancer | HLA-DQB1*, HLA-DQB2 | H2-Ab1 | Alliance of Genome Resources | ||||
| vulva squamous cell carcinoma | SFN* | Sfn | Alliance of Genome Resources | ||||
| vulvovaginal candidiasis | MBL2* | Mbl2 | Alliance of Genome Resources | ||||
| X-linked congenital bilateral absence of vas deferens | ADGRG2* | Adgrg2 | Alliance of Genome Resources | ||||
| X-linked spermatogenic failure 2 | TEX11* | Tex11 | Alliance of Genome Resources | ||||
| X-linked spermatogenic failure 3 | CFAP47* | Cfap47 | Alliance of Genome Resources | ||||
| X-linked spermatogenic failure 4 | GCNA* | ||||||
| X-linked spermatogenic failure 5 | SSX1*, SSX2, SSX2B, SSX3, SSX4, SSX4B, SSX5, SSX6P, SSX7, SSX8P, SSX9P | Ssxa1, Ssxb1, Ssxb2, Ssxb3, Ssxb5, Ssxb6, Ssxb8, Ssxb9, Ssxb10, Ssxb13, Ssxb14, Ssxb15, Ssxb16 | Alliance of Genome Resources | ||||
| X-linked spermatogenic failure 6 | USP26* | Usp26 | Alliance of Genome Resources | ||||
| X-linked spermatogenic failure 7 | CT55* | Ct55 | Alliance of Genome Resources | ||||
| X-linked spermatogenic failure 8 | CYLC1* | Cylc1 | Alliance of Genome Resources | ||||
| Y-linked spermatogenic failure 2 | USP9Y* | Usp9y | Alliance of Genome Resources | ||||
Excel File
|
Transgenes and other genome features developed in mice to model this disease.
|
|||
| Disease Term | Transgenes and Other Genome Features | Mouse Models | |
| aromatase excess syndrome | Tg(Cyp19)C2-3Rrte | 1 model | |
| dermoid cyst of ovary | Tg(Amh-SMAD2*)#Jebu | 1 model | |
| endosalpingiosis | Tg(Amh-SMAD2*)2Tkw | 1 model | |
| infertility | Rr401 | 1 model | |
| male infertility | Rr401 | 1 model | |
| ovarian cancer | Tg(CAG-lacZ,-SV40)#Bcv | 1 model | |
| ovarian cancer | Tg(Amhr2-SV40TAg)1Dcco | 1 model | |
| polycystic ovary syndrome | Tg(Cyp17a1-NGF)2456Oje | 1 model | |
| prostate adenocarcinoma | Tg(Pbsn-Tag)12T10Rjm | 1 model | |
| prostate cancer | Tg(ARR2/Pbsn-MYC)7Key | 1 model | |
| prostate cancer | Tg(C3-1-TAg)cJeg | 1 model | |
| prostate cancer | Tg(Ggamma-T)15Cps | 2 models | |
| prostate cancer | Tg(Msmb-TAg)183-2Xuan | 1 model | |
| prostate cancer | Tg(Msmb-TAg)186-3Xuan | 1 model | |
| prostate cancer | Tg(Pbsn-Ar*E231G)7353Ng | 1 model | |
| prostate cancer | Tg(Pbsn-ERG*)1Vv | 1 model | |
| prostate cancer | Tg(Pbsn-Fgfr1/Fkbp1a)#aDmsp | 2 models | |
| prostate cancer | Tg(Pbsn-MYC)6Key | 1 model | |
| prostate cancer | Tg(Pbsn-MYC)#Tt | 1 model | |
| prostate cancer | Tg(Pbsn-Tag)12T7fRjm | 1 model | |
| prostate cancer | Tg(Pbsn-TAg)15Tvd | 2 models | |
| prostate cancer | Tg(TRAMP)8247Ng | 6 models | |
| uterine cancer | Tg(H2-K-Hmga1)#Lmsr | 1 model | |